Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-11-19
1984-09-25
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 3158
Patent
active
044735650
ABSTRACT:
A pharmaceutical composition for topical treatment of cutaneous disorders or disruptions characterized by skin inflammation or hyperproliferative epidermal activity comprises the combination of a topically active anti-inflammatory corticosteroid and a non-steroidal anti-inflammatory agent which is an inhibitor of prostaglandin synthetase selected from the group consisting of the hydratropic acid derivatives; acetylsalicylic acid; the pyrazolon derivatives; the fenamic acid derivatives; the aroyl-substituted pyrroles and the substituted arylacetohydroxamic acids in a pharmaceutically acceptable topical vehicle. Treatment of above cutaneous disorders may also be effected by concurrent therapy using separate applications of corticosteroid and non-steroid.
REFERENCES:
patent: 3479396 (1969-11-01), Buu-Hoi et al.
Floman et al., Investigative Ophtholmology & Visual Science, vol. 16, No. 1, pp. 69-73, (1977).
Lisciani et al., Japan J. Pharmacol, 25, pp. 101-107, (1975).
Merck Index, 9th Ed., (1976), pp. 946-947.
Marvel John R.
Mezick James A.
Rovee David T.
Friedman Stanley J.
Johnson & Johnson
Lambert Benjamin F.
LandOfFree
Topical anti-inflammatory drug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical anti-inflammatory drug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical anti-inflammatory drug therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1769447